UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040289
Receipt number R000045947
Scientific Title Simulation study of tracheal intubation through an aerosol-box assuming COVID-19
Date of disclosure of the study information 2020/05/01
Last modified on 2020/11/15 19:28:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Simulation study of tracheal intubation through an aerosol-box assuming COVID-19

Acronym

Simulation study of tracheal intubation through an aerosol-box assuming COVID-19

Scientific Title

Simulation study of tracheal intubation through an aerosol-box assuming COVID-19

Scientific Title:Acronym

Simulation study of tracheal intubation through an aerosol-box assuming COVID-19

Region

Japan


Condition

Condition

Patients with infectious diseases assuming COVID-19

Classification by specialty

Anesthesiology Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the difficulty of intubation through an aerosol-box used for COVID-19 patients and the appropriate device for intubation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time required to intubate the mannequin

Key secondary outcomes

Difficulty of tracheal intubation and mask ventilation, and Cormack grade


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Volunteer doctorss in Tokyo Women's Medical University Hospital

Key exclusion criteria

doctors who refused to participate

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Idei
Middle name
Last name Masafumi

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Intensive Care Medicine

Zip code

162-8666

Address

8-1Kawada-cho, Shinjuku, Tokyo, Japan

TEL

0333538111

Email

masafumi203@gmail.com


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Idei

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Intensive Care Medicine

Zip code

162-8666

Address

8-1Kawada-cho, Shinjuku, Tokyo, Japan

TEL

0333538111

Homepage URL


Email

masafumi203@gmail.com


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Women's Medical University

Address

8-1 Kawada-cho, Shinjuku, Tokyo

Tel

0333538111

Email

krinri.bm@twmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 10 Month 12 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 05 Month 01 Day

Date of IRB

2020 Year 05 Month 01 Day

Anticipated trial start date

2020 Year 05 Month 01 Day

Last follow-up date

2020 Year 05 Month 08 Day

Date of closure to data entry

2020 Year 05 Month 08 Day

Date trial data considered complete

2020 Year 06 Month 01 Day

Date analysis concluded

2020 Year 06 Month 02 Day


Other

Other related information

This is a simulation study of tracheal intubation and mask ventilation for mannequins with and without an aerosol-box in doctors at Tokyo Women's Medical University Hospital.

protocol of procedure

We ask the participants to perform the intubation using three different devices with and without aerosol box (SplashGuardCG:SGCG), which gives six attempts in each. The orders of procedure are randomized using lottery metod.

Intubation devices
Macintosh Laryngoscope (ML) (Riester, Jungignen, Germany) with size 3 blade
AirWay ScopeTM S-100 (AWS) (Pentax, Tokyo, Japan)
McGRATH MACTM (MAC) (Aircraft Medical Ltd., Edinburgh, UK) with size 3 blade

Tracheal tube
7.0 mm cuffed tracheal tube (SealGuard EvacTM, Covidien, Dublin, Ireland)
stylet (ShileyTM Intubation Stylet, Covidien, Dublin, Ireland) (when intubating with ML and MAC)

Simulation manikin
Laerdal Airway Management Trainer (Laerdal Medical Japan Ltd., Tokyo, Japan) on the bed in our intensive care unit (ICU)
The height of the bed and the pillow, and the position of the manikin are freely adjusted by the participants.

Support of procedure
The same certified anesthesiologist supports as requested by the subjects, such as inflating a cuff, removing a stylet, or performing the backward upward and rightward pressure (BURP) maneuver through the right holes of aerosol box (SGCG).

Intubation time
We define the intubation time as the time taken from the participants held the intubation device until the ventilation with bag valve mask via the successfully placed endotracheal tube was confirmed.


Management information

Registered date

2020 Year 05 Month 01 Day

Last modified on

2020 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045947


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name